New perspectives in the treatment of idiopathic pulmonary fibrosis (Q37362597)

19 August 2017

1 reference

title

New perspectives in the treatment of idiopathic pulmonary fibrosis (English)

1 reference

19 August 2017

1 reference

Paola Rogliani

1 reference

19 August 2017

Marco Mura

series ordinal

1 reference

19 August 2017

Maria Assunta Porretta

series ordinal

1 reference

19 August 2017

Cesare Saltini

series ordinal

1 reference

19 August 2017

publication date

1 April 2008

1 reference

Therapeutic advances in respiratory disease

19 August 2017

published in

1 reference

19 August 2017

1 reference

19 August 2017

1 reference

19 August 2017

page(s)

75-93

1 reference

Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis.

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Platelet-derived growth factor in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Imatinib as a novel antifibrotic agent in bleomycin-induced pulmonary fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Glutathione deficiency of the lower respiratory tract in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Mechanisms of pulmonary fibrosis. Spontaneous release of the alveolar macrophage-derived growth factor in the interstitial lung disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Effect of glutathione aerosol on oxidant-antioxidant imbalance in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Oxidant-mediated epithelial cell injury in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Acute exacerbations of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Sildenafil improves walk distance in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Combined corticosteroid and cyclophosphamide therapy does not alter survival in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Immunomodulatory agents for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

High-dose acetylcysteine in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Fibroblast-specific Expression of a Kinase-deficient Type II Transforming Growth Factor β (TGFβ) Receptor Leads to Paradoxical Activation of TGFβ Signaling Pathways with Fibrosis in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Etanercept: a review of its use in the management of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Colchicine versus prednisone in the treatment of idiopathic pulmonary fibrosis. A randomized prospective study. Members of the Lung Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Idiopathic pulmonary fibrosis: Impact of oxygen and colchicine, prednisone, or no therapy on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Inhibition of TGF-beta induced lung fibroblast to myofibroblast conversion by phosphodiesterase inhibiting drugs and activators of soluble guanylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Cytokine networks in the regulation of inflammation and fibrosis in the lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Risk: benefit profile of etanercept in elderly patients with rheumatoid arthritis, ankylosing spondylitis or psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Sildenafil citrate therapy for pulmonary arterial hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Mapping of topoisomerase II alpha epitopes recognized by autoantibodies in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Idiopathic Pulmonary Fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

High-dose intravenous methylprednisolone pulse therapy as initial treatment in cryptogenic fibrosing alveolitis. A pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Molecular mechanisms of antifibrotic effect of interferon gamma in bleomycin-mouse model of lung fibrosis: downregulation of TGF-beta and procollagen I and III gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Acute respiratory failure after interferon-gamma therapy of end-stage pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Role of thrombin and its major cellular receptor, protease-activated receptor-I, in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Mechanisms of neutrophil accumulation in the lungs of patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Evidence that fibroblasts derive from epithelium during tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Randomised controlled trial comparing prednisolone alone with cyclophosphamide and low dose prednisolone in combination in cryptogenic fibrosing alveolitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Pirfenidone attenuates expression of HSP47 in murine bleomycin-induced pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Idiopathic pulmonary fibrosis: clinical relevance of pathologic classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Idiopathic pulmonary fibrosis: relationship between histopathologic features and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

BUILD-1: a randomized placebo-controlled trial of bosentan in idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Extracellular superoxide dismutase has a highly specific localization in idiopathic pulmonary fibrosis/usual interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Anticoagulant therapy for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Oxidative stress in lung epithelial cells from patients with idiopathic interstitial pneumonias

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Transforming growth factor-beta(1) overexpression in tumor necrosis factor-alpha receptor knockout mice induces fibroproliferative lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Tumor necrosis factor-alpha overexpression in lung disease: a single cause behind a complex phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Idiopathic pulmonary fibrosis: multiple causes and multiple mechanisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Cyclosporin as a treatment for interstitial lung disease of unknown aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Epithelial necrosis and alveolar collapse in the pathogenesis of usual interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

A novel anti-fibrotic agent pirfenidone suppresses tumor necrosis factor-alpha at the translational level

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

The relationship between individual histologic features and disease progression in idiopathic pulmonary fibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Somatostatin and its receptor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

In vivo levels and in vitro production of interferon-gamma in fibrosing interstitial lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

A placebo-controlled trial of interferon gamma-1b in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Fibroblasts from idiopathic pulmonary fibrosis and normal lungs differ in growth rate, apoptosis, and tissue inhibitor of metalloproteinases expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Production of fibronectin by the human alveolar macrophage: mechanism for the recruitment of fibroblasts to sites of tissue injury in interstitial lung diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Elevated expression of endothelin-1 and endothelin-converting enzyme-1 in idiopathic pulmonary fibrosis: possible involvement of proinflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Pulmonary fibrosis: a cellular overreaction or a failure of communication?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Fibroblast matrix gene expression and connective tissue remodeling: role of endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Pathogenesis and natural history of usual interstitial pneumonia: the whole story or the last chapter of a long novel

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Thalidomide prevents bleomycin-induced pulmonary fibrosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Thalidomide reduces tumour necrosis factor-alpha production by human alveolar macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

A pilot study of aerosolized N-acetylcysteine for idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Current perspectives on the treatment of idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Detection of antivimentin antibody in sera of patients with idiopathic pulmonary fibrosis and non-specific interstitial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

Autoantibody to alanyl-tRNA synthetase in patients with idiopathic pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1753465808089363

21 January 2018

Identifiers

DOI

10.1177/1753465808089363

1 reference

19 August 2017

1 reference